ITGAM and glioblastoma: To distinguish the MDM from the GBM cells we used CD11b and CD14 markers, which allow us to differentiate two sub-populations based on the acquisition of high and low levels of CD14 expression (CD11b+CD14high and CD11b+CD14low) (Figure 4a).